- Home
- GGT vs FENC Comparison
GGT vs FENC Comparison
Compare GGT & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGT
- FENC
- Stock Information
- Founded
- GGT 1994
- FENC 1996
- Country
- GGT United States
- FENC United States
- Employees
- GGT N/A
- FENC N/A
- Industry
- GGT Trusts Except Educational Religious and Charitable
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GGT Finance
- FENC Health Care
- Exchange
- GGT Nasdaq
- FENC Nasdaq
- Market Cap
- GGT N/A
- FENC 156.9M
- IPO Year
- GGT N/A
- FENC 2001
- Fundamental
- Price
- GGT $4.64
- FENC $5.53
- Analyst Decision
- GGT
- FENC Strong Buy
- Analyst Count
- GGT 0
- FENC 2
- Target Price
- GGT N/A
- FENC $14.00
- AVG Volume (30 Days)
- GGT 59.7K
- FENC 126.0K
- Earning Date
- GGT 01-01-0001
- FENC 05-13-2025
- Dividend Yield
- GGT 15.56%
- FENC N/A
- EPS Growth
- GGT N/A
- FENC N/A
- EPS
- GGT 0.83
- FENC N/A
- Revenue
- GGT N/A
- FENC $47,538,000.00
- Revenue This Year
- GGT N/A
- FENC $2.68
- Revenue Next Year
- GGT N/A
- FENC $71.63
- P/E Ratio
- GGT $6.90
- FENC N/A
- Revenue Growth
- GGT N/A
- FENC 123.69
- 52 Week Low
- GGT $4.32
- FENC $3.96
- 52 Week High
- GGT $7.00
- FENC $11.29
- Technical
- Relative Strength Index (RSI)
- GGT 37.80
- FENC 30.64
- Support Level
- GGT $4.56
- FENC $6.25
- Resistance Level
- GGT $4.94
- FENC $6.90
- Average True Range (ATR)
- GGT 0.10
- FENC 0.36
- MACD
- GGT -0.01
- FENC -0.09
- Stochastic Oscillator
- GGT 21.05
- FENC 4.20
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.